查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614374

固定剂量设备市场：按设备类型、适应症、分销管道和最终用户划分 - 2025-2030 年全球预测

Fixed Dose Device Market by Device Type (Inhalers, Injectors, Nasal Sprays), Indication (Cardiovascular Diseases, Diabetes, Respiratory Disorders), Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年固定剂量器械市场价值为91.7亿美元，预计到2024年将达到100.3亿美元，复合年增长率为9.78%，到2030年将达到176.3亿美元。

固定剂量设备市场包括旨在准确管理预设剂量药物的医疗传输设备。这个市场对于确保一致的药物传递和最小的使用者错误至关重要，这对于需要严格剂量的治疗（例如糖尿病的胰岛素）至关重要。对计量装置的需求源自于对剂量准确性、病人依从性和易用性的需求，尤其是在居家照护环境中。其应用涵盖多种治疗领域，包括慢性病、疼痛管理和紧急药物管理。最终用户主要是患者、医疗保健专业人员和家庭护理师。该市场的主要成长要素是慢性病盛行率的增加、人口老化的加剧以及家庭医疗保健的成长趋势。智慧和连网型设备等医疗技术的进步为加强患者管理和疾病监测提供了重要机会。然而，市场开拓可能会受到先进设备的高成本、监管挑战以及开发新医疗设备相关的复杂性等因素的阻碍。为了应对这些限制，公司可以专注于具有成本效益的製造流程，并与医疗保健提供者合作，简化监管核准流程。创新地，有潜力开发整合人工智慧的设备，以进行即时患者回馈和依从性监测。此外，增加设备连接性可以实现更好的资料分析和患者管理解决方案。对生物分解性和患者客製化设计的研究也可以刺激业务成长。由于技术进步和不断变化的患者需求，市场竞争激烈且快速发展。希望利用这一市场的公司需要投资于研发，注重策略伙伴关係关係，并灵活应对监管变化和竞争环境，以确保成长和市场渗透。

主要市场统计
基准年[2023] 91.7亿美元
预计年份 [2024] 100.3亿美元
预测年份 [2030] 176.3亿美元
复合年增长率（%） 9.78%

市场动态：针对快速发展的固定剂量设备市场所揭示的关键市场见解

供需的动态交互作用正在改变固定剂量设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于慢性病的流行，对持续用药管理的需求增加
    • 由于方便和准确，计量装置迅速普及
  • 市场限制因素
    • 固定剂量装置的开发和製造成本较高
  • 市场机会
    • 科技不断进步，开发智慧计量笔
    • 药厂加大定量装置研发投入
  • 市场挑战
    • 政府机构严格的监管标准和复杂的核准流程

波特的五力：驾驭固定剂量设备市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解固定剂量设备市场的外部影响

外部宏观环境因素在塑造固定剂量设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解固定剂量装置市场的竞争格局

固定剂量设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵固定剂量设备市场供应商的绩效评估

FPNV 定位矩阵是评估固定剂量设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘固定剂量设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对固定剂量设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的增加增加了对持续药物管理的需求
      • 便利性和准确性导致固定剂量设备的快速采用
    • 抑制因素
      • 开发和製造固定剂量装置的成本高昂
    • 机会
      • 持续技术进步，开发智慧固定剂量笔
      • 药厂加大固定剂量器材研发投入
    • 任务
      • 政府机构严格的监管标准和复杂的核准流程
  • 市场区隔分析
    • 设备类型：鼻喷剂因其有效输送药物而受到青睐
    • 配送通路：拓展线上配送通路，方便偏远地区配送
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依设备类型分類的固定剂量设备市场

  • 吸入器
  • 注射器
  • 鼻喷剂
  • 经皮吸收贴片

第七章依适应症分類的固定剂量装置市场

  • 心血管疾病
  • 糖尿病
  • 呼吸系统疾病

第八章固定剂量设备市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第九章固定剂量设备市场：依最终用户分类

  • 家庭护理设置
  • 医院/诊所

第10章美洲固定剂量设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太固定剂量设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的固定剂量设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 印度製药商旨在透过非专利药 Wegovy 占领全球减重药市场
    • 欧盟对礼来公司用于糖尿病治疗的多剂量注射笔「Mounjaro」进行监管审查
    • 诺和诺德以 1.54 亿美元收购 BioCorp，扩大产品组合
  • 战略分析和建议

公司名单

  • Becton, Dickinson and Company
  • CeQur Corporation
  • Eli Lilly and Company
  • Gerresheimer AG
  • Insulet Corporation
  • Medtronic plc
  • Nemera Development SA
  • Novo Holdings A/S
  • Owen Mumford Limited
  • Phillips-Medisize by Koch Industries, Inc.
  • Sanofi Winthrop Industrie
  • SHL Medical AG.
  • Solteam Incorporation Co., Ltd.
  • SOOIL Developments Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Tata Elxsi Limited by Tata Group
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co
  • Ypsomed Holding AG
Product Code: MRR-5D693B46C669

The Fixed Dose Device Market was valued at USD 9.17 billion in 2023, expected to reach USD 10.03 billion in 2024, and is projected to grow at a CAGR of 9.78%, to USD 17.63 billion by 2030.

The fixed dose device market encompasses medical delivery devices designed to administer a precise and pre-set quantity of medication. This market is vital in ensuring consistent drug delivery with minimal user error, which is critical for treatments requiring strict dosage adherence, like insulin for diabetes. The necessity of fixed dose devices arises from the need for accuracy in dosing, patient compliance, and ease of use, especially in home-care settings. Their applications span various therapeutic areas including chronic diseases, pain management, and emergency medication administration. End-users predominantly include patients, healthcare professionals, and home nurses. Key growth factors for this market are the increasing incidence of chronic diseases, a growing aging population, and the rising trend of home healthcare. Advancements in medical technology, such as smart and connected devices, offer substantial opportunities for enhanced patient management and disease monitoring. However, market growth may be hampered by factors like high costs of advanced devices, regulatory challenges, and the complexities involved in developing devices for new drugs. To counter these limitations, companies can focus on cost-effective manufacturing processes and work with healthcare providers to streamline regulatory approval processes. Innovatively, there is potential in developing devices with integrated AI for real-time patient feedback and adherence monitoring. Moreover, enhancing device connectivity could allow for better data analytics and patient management solutions. Researching biodegradability and patient-customized designs may also spur business growth. The nature of the fixed dose device market is competitive and rapidly evolving, driven by technological advancements and shifting patient needs. Companies seeking to capitalize on this market should invest in R&D, focus on strategic partnerships, and remain agile to adapt to regulatory changes and competitive environments, ensuring robust growth and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 9.17 billion
Estimated Year [2024] USD 10.03 billion
Forecast Year [2030] USD 17.63 billion
CAGR (%) 9.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fixed Dose Device Market

The Fixed Dose Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased demand for consistent medication management due to growing prevalence of chronic disease
    • Rapid adoption of fixed-dose devices due to its convenience and accuracy
  • Market Restraints
    • High costs of development and manufacturing of fixed dose device
  • Market Opportunities
    • Ongoing technological advancements for the development of smart fixed-dose pens
    • Rising investments in research and development of fixed-dose devices by pharmaceutical companies
  • Market Challenges
    • Stringent regulatory norms and complex approval processes by government bodies

Porter's Five Forces: A Strategic Tool for Navigating the Fixed Dose Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fixed Dose Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fixed Dose Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fixed Dose Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fixed Dose Device Market

A detailed market share analysis in the Fixed Dose Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fixed Dose Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fixed Dose Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fixed Dose Device Market

A strategic analysis of the Fixed Dose Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fixed Dose Device Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, CeQur Corporation, Eli Lilly and Company, Gerresheimer AG, Insulet Corporation, Medtronic plc, Nemera Development S.A., Novo Holdings A/S, Owen Mumford Limited, Phillips-Medisize by Koch Industries, Inc., Sanofi Winthrop Industrie, SHL Medical AG., Solteam Incorporation Co., Ltd., SOOIL Developments Co., Ltd, Tandem Diabetes Care, Inc., Tata Elxsi Limited by Tata Group, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH & Co, and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Fixed Dose Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Inhalers, Injectors, Nasal Sprays, and Transdermal Patches.
  • Based on Indication, market is studied across Cardiovascular Diseases, Diabetes, and Respiratory Disorders.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on End-User, market is studied across Home Care Settings and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand for consistent medication management due to growing prevalence of chronic disease
      • 5.1.1.2. Rapid adoption of fixed-dose devices due to its convenience and accuracy
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of development and manufacturing of fixed dose device
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements for the development of smart fixed-dose pens
      • 5.1.3.2. Rising investments in research and development of fixed-dose devices by pharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory norms and complex approval processes by government bodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Preference towards nasal spray due to its efficient delivery of drugs
    • 5.2.2. Distribution Channel: Expanding online delivery channels due to convenient delivery for remote locations
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fixed Dose Device Market, by Device Type

  • 6.1. Introduction
  • 6.2. Inhalers
  • 6.3. Injectors
  • 6.4. Nasal Sprays
  • 6.5. Transdermal Patches

7. Fixed Dose Device Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiovascular Diseases
  • 7.3. Diabetes
  • 7.4. Respiratory Disorders

8. Fixed Dose Device Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Fixed Dose Device Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Care Settings
  • 9.3. Hospitals & Clinics

10. Americas Fixed Dose Device Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Fixed Dose Device Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Fixed Dose Device Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Indian Pharmaceutical Firms Target Global Weight-Loss Drug Market with Generic Versions of Wegovy
    • 13.3.2. EU Regulatory Review of Lilly's Mounjaro Multi-Dose Pen for Diabetes Treatment
    • 13.3.3. Novo Nordisk Expands Portfolio with USD 154 Million Acquisition of Biocorp
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. CeQur Corporation
  • 3. Eli Lilly and Company
  • 4. Gerresheimer AG
  • 5. Insulet Corporation
  • 6. Medtronic plc
  • 7. Nemera Development S.A.
  • 8. Novo Holdings A/S
  • 9. Owen Mumford Limited
  • 10. Phillips-Medisize by Koch Industries, Inc.
  • 11. Sanofi Winthrop Industrie
  • 12. SHL Medical AG.
  • 13. Solteam Incorporation Co., Ltd.
  • 14. SOOIL Developments Co., Ltd
  • 15. Tandem Diabetes Care, Inc.
  • 16. Tata Elxsi Limited by Tata Group
  • 17. West Pharmaceutical Services, Inc.
  • 18. Wilhelm Haselmeier GmbH & Co
  • 19. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. FIXED DOSE DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. FIXED DOSE DEVICE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FIXED DOSE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FIXED DOSE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FIXED DOSE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FIXED DOSE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FIXED DOSE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FIXED DOSE DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FIXED DOSE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES FIXED DOSE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FIXED DOSE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM FIXED DOSE DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. FIXED DOSE DEVICE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. FIXED DOSE DEVICE MARKET, FPNV POSITIONING MATRIX, 2023